ONCY (Oncolytics Biotech) Cyclically Adjusted Book per Share: $0.45 (As of Mar. 2026)


ONCY Oncolytics Biotech Inc ONCY
32 GF Score
Price $0.90
! 2 Warning Signs
View Full Analysis

What is Oncolytics Biotech Cyclically Adjusted Book per Share?

Oncolytics Biotech ONCY -0.18% 32 Cyclically Adjusted Book per Share is $0.45 as of Mar. 2026. GuruFocus rates ONCY with a GF Score™ of 32/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Oncolytics Biotech's adjusted book value per share for the three months ended in Mar. 2026 was $-0.044. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.45 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Oncolytics Biotech's average Cyclically Adjusted Book Growth Rate was -30.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -26.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -24.60% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -19.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Oncolytics Biotech was -2.30% per year. The lowest was -26.90% per year. And the median was -16.00% per year.

As of today (2026-07-05), Oncolytics Biotech's current stock price is $0.8991. Oncolytics Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $0.45. Oncolytics Biotech's Cyclically Adjusted PB Ratio of today is 2.00.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Oncolytics Biotech was 2.01. The lowest was 0.00. And the median was 0.00.


Oncolytics Biotech  (NAS:ONCY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Oncolytics Biotech's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.8991/0.45
=2.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Oncolytics Biotech was 2.01. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Oncolytics Biotech Cyclically Adjusted Book per Share Related Terms


Oncolytics Biotech Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Oncolytics Biotech's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncolytics Biotech Cyclically Adjusted Book per Share Chart

Oncolytics Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.53 1.23 0.86 0.70 0.48

Oncolytics Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.59 0.53 0.48 0.45

ONCY vs VRCA, ENGN, ALDX: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Oncolytics Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncolytics Biotech Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncolytics Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Oncolytics Biotech's Cyclically Adjusted PB Ratio falls into.


ONCY
32GF Score
Oncolytics Biotech Inc ONCY
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oncolytics Biotech Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Oncolytics Biotech's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.044/330.2130*330.2130
=-0.044

Current CPI (Mar. 2026) = 330.2130.

Oncolytics Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.148 241.018 1.573
201609 0.934 241.428 1.277
201612 0.623 241.432 0.852
201703 0.427 243.801 0.578
201706 0.749 244.955 1.010
201709 0.657 246.819 0.879
201712 0.441 246.524 0.591
201803 0.245 249.554 0.324
201806 0.505 251.989 0.662
201809 0.414 252.439 0.542
201812 0.261 251.233 0.343
201903 0.224 254.202 0.291
201906 0.142 256.143 0.183
201909 0.104 256.759 0.134
201912 -0.003 256.974 -0.004
202003 0.437 258.115 0.559
202006 0.430 257.797 0.551
202009 0.370 260.280 0.469
202012 0.420 260.474 0.532
202103 0.670 264.877 0.835
202106 0.682 271.696 0.829
202109 0.609 274.310 0.733
202112 0.514 278.802 0.609
202203 0.488 287.504 0.560
202206 0.413 296.311 0.460
202209 0.354 296.808 0.394
202212 0.318 296.797 0.354
202303 0.298 301.836 0.326
202306 0.255 305.109 0.276
202309 0.291 307.789 0.312
202312 0.279 306.746 0.300
202403 0.225 312.332 0.238
202406 0.174 314.175 0.183
202409 0.087 315.301 0.091
202412 0.041 315.605 0.043
202503 0.053 319.799 0.055
202506 0.046 322.561 0.047
202509 0.001 324.800 0.001
202512 -0.035 324.054 -0.036
202603 -0.044 330.213 -0.044

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.45 mean?
Oncolytics Biotech (ONCY) has a Cyclically Adjusted Book per Share of $0.45 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Oncolytics Biotech and its competitors.
Is Oncolytics Biotech's Cyclically Adjusted Book per Share too high?
Oncolytics Biotech's current Cyclically Adjusted Book per Share is $0.45. Overall, Oncolytics Biotech has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Oncolytics Biotech's Cyclically Adjusted Book per Share compare to VRCA and ENGN?
Oncolytics Biotech's Cyclically Adjusted Book per Share of $0.45 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Oncolytics Biotech and its competitors. Oncolytics Biotech's current Cyclically Adjusted Book per Share is $0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncolytics Biotech stock overvalued right now?
Oncolytics Biotech (ONCY) has a current Cyclically Adjusted Book per Share of $0.45. The current Cyclically Adjusted Book per Share is $0.45. Oncolytics Biotech's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Oncolytics Biotech (ONCY), the current Cyclically Adjusted Book per Share is $0.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oncolytics Biotech Business Description

Address 4350 Executive Drive, Suite 325, San Diego, CA, USA, 92121
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
32GF Score

Get the complete analysis for ONCY

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.90
Price